company background image
VDP logo

Vidipha Central Pharmaceutical HOSE:VDP Stock Report

Last Price

₫35.40k

Market Cap

₫781.8b

7D

5.4%

1Y

8.9%

Updated

30 Dec, 2024

Data

Company Financials

Vidipha Central Pharmaceutical Joint Stock Company

HOSE:VDP Stock Report

Market Cap: ₫781.8b

VDP Stock Overview

Produces and sells pharmaceutical products under the Vidipha brand. More details

VDP fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health0/6
Dividends1/6

Risk Analysis

Has not reported any financial data

Does not have a meaningful market cap (₫782B)


My Notes

Capture your thoughts, links and company narrative

Vidipha Central Pharmaceutical Joint Stock Company Competitors

Pharmedic Pharmaceutical Medicinal

HNX:PMC

₫1.0t

Central Pharmaceutical No3

HNX:DP3

₫1.2t

OPC Pharmaceutical

HOSE:OPC

₫1.5t

Mediplantex National Pharmaceutical

HNX:MED

₫310.3b

Price History & Performance

Summary of share price highs, lows and changes for Vidipha Central Pharmaceutical
Historical stock prices
Current Share Price₫35,400.00
52 Week High₫40,800.00
52 Week Low₫30,833.33
Beta0
1 Month Change-5.60%
3 Month Change7.27%
1 Year Change8.92%
3 Year Change9.48%
5 Year Change30.91%
Change since IPO25.13%

Recent News & Updates

Recent updates

Shareholder Returns

VDPVN PharmaceuticalsVN Market
7D5.4%-3.0%0.9%
1Y8.9%28.1%11.0%

Return vs Industry: VDP underperformed the VN Pharmaceuticals industry which returned 29.6% over the past year.

Return vs Market: VDP underperformed the VN Market which returned 11.4% over the past year.

Price Volatility

Is VDP's price volatile compared to industry and market?
VDP volatility
VDP Average Weekly Movement4.3%
Pharmaceuticals Industry Average Movement3.8%
Market Average Movement3.7%
10% most volatile stocks in VN Market7.1%
10% least volatile stocks in VN Market2.0%

Stable Share Price: VDP has not had significant price volatility in the past 3 months compared to the VN market.

Volatility Over Time: VDP's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
n/an/aHoa Van Hoangwww.vidipha.com.vn

Vidipha Central Pharmaceutical Joint Stock Company produces and sells pharmaceutical products under the Vidipha brand. The company primarily provides antibiotics, anti-inflammatory, vitamins and mineral salts, pain relievers, antipyretics, anti-allergy drugs, and other medicines for the treatment of worm, fluke, respiratory, gastrointestinal, and skin diseases. It offers its products in the form of compress and capsule Pills, Powdered granules, powder and liquid Injections, Syrups, drinking tubes, Eye and nose drops, Topical creams, and ointments.

Vidipha Central Pharmaceutical Joint Stock Company Fundamentals Summary

How do Vidipha Central Pharmaceutical's earnings and revenue compare to its market cap?
VDP fundamental statistics
Market cap₫781.76b
Earnings (TTM)₫0
Revenue (TTM)n/a

n/a

P/E Ratio

n/a

P/S Ratio

Is VDP overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
VDP income statement (TTM)
Revenue₫0
Cost of Revenue₫0
Gross Profit₫0
Other Expenses₫0
Earnings₫0

Last Reported Earnings

n/a

Next Earnings Date

n/a

Earnings per share (EPS)0
Gross Margin0.00%
Net Profit Margin0.00%
Debt/Equity Ratio0.0%

How did VDP perform over the long term?

See historical performance and comparison

Dividends

6.4%

Current Dividend Yield

n/a

Payout Ratio

Does VDP pay a reliable dividends?

See VDP dividend history and benchmarks
When do you need to buy VDP by to receive an upcoming dividend?
Vidipha Central Pharmaceutical dividend dates
Ex Dividend DateDec 13 2024
Dividend Pay DateJan 16 2025
Days until Ex dividend18 days
Days until Dividend pay date16 days

Does VDP pay a reliable dividends?

See VDP dividend history and benchmarks

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/30 05:36
End of Day Share Price 2024/12/30 00:00
EarningsN/A
Annual EarningsN/A

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Vidipha Central Pharmaceutical Joint Stock Company is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Hang Thi HaBao Viet Securities Joint Stock Company